FDA Approves New Corticosteroid Spray for Psoriasis

04/15/2013

The FDA has approved Topicort® (desoximetasone) Topical Spray, 0.25%, for the treatment of plaque psoriasis. According manufacturer Taro Pharmaceuticals, Topicort Spray is indicated for patients 18 years of age or older.
Register

We're glad to see you're enjoying PracticalDermatology…
but how about a more personalized experience?

Register for free